Brahms AG

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Completed	Risk Stratification Using Midregional Proadrenomedullin in the ED Patients Presenting With Suspicion of Infection to the ED	N/A	2021-10-14
Completed	Chromogranin A as Blood Marker in Cancer Patients Gastric Neoplasms, Pancreatic Neoplasms, Small Intestinal Neoplasms	—	2019-01-29
Completed	Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pil Patients Presenting With Suspicion of Infection to the ED	N/A	2018-12-14
Terminated	Improve Management of Heart Failure With Procalcitonin Heart Failure, Infection	N/A	2015-03-01
Completed	Procalcitonin Monitoring Sepsis Study Severe Sepsis, Septic Shock	—	2011-12-01
Completed	Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction Acute Coronary Syndromes	—	2009-08-01
Terminated	Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection Infection, Bacterial Infection, Sepsis	Phase 4	2008-07-01
Completed	Biomarkers in Acute Heart Failure Shortness of Breath, Heart Failure	—	2007-03-01